1,647
Views
7
CrossRef citations to date
0
Altmetric
Editorial

The evolution of radiotherapy techniques in the management of prostate cancer

, &
Pages 821-824 | Received 03 May 2015, Accepted 03 May 2015, Published online: 14 May 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Olav Dahl, Jon Espen Dale & Marianne Brydøy. (2019) Rationale for combination of radiation therapy and immune checkpoint blockers to improve cancer treatment. Acta Oncologica 58:1, pages 9-20.
Read now

Articles from other publishers (6)

Eva Y. W. Cheung, Shirley S. H. Ng, Sapphire H. Y. Yung, Dominic Y. T. Cheng, Fandy Y. C. Chan & Janice K. Y. Cheng. (2022) Multi-Planar VMAT Plans for High-Grade Glioma and Glioblastoma Targeting the Hypothalamic-Pituitary Axis Sparing. Life 12:2, pages 195.
Crossref
Stacey Murray, Terri M Gilleece & Paul H Shepherd. (2018) Evaluating the effectiveness of the clinical research radiographer undertaking the on-treatment review of clinical trial patients receiving radiotherapy for prostate cancer. Journal of Radiotherapy in Practice 18:2, pages 123-126.
Crossref
T. Mee, N.F. Kirkby & K.J. Kirkby. (2018) Mathematical Modelling for Patient Selection in Proton Therapy. Clinical Oncology 30:5, pages 299-306.
Crossref
I G Isaev, F A Guliev, K S Akperov & N R Alieva. (2017) Analysis of the frequency of radiation therapy complications in patients with prostate cancer. Kazan medical journal 98:5, pages 680-686.
Crossref
Gustavo Arruda Viani, Bruno Silveira Viana, Jose Eduardo Chicareli Martin, Bruno Tiago Rossi, Gisele Zuliani & Eduardo Jose Stefano. (2016) Intensity-modulated radiotherapy reduces toxicity with similar biochemical control compared with 3-dimensional conformal radiotherapy for prostate cancer: A randomized clinical trial. Cancer 122:13, pages 2004-2011.
Crossref
Yan-Ru Zeng, Zhao-Dong Han, Cong Wang, Chao Cai, Ya-Qiang Huang, Hong-Wei Luo, Ze-Zhen Liu, Yang-Jia Zhuo, Qi-Shan Dai, Hai-Bo Zhao, Yu-Xiang Liang & Wei-De Zhong. (2015) Overexpression of NIMA-related kinase 2 is associated with progression and poor prognosis of prostate cancer. BMC Urology 15:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.